Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30106% above fair value
$146.95−0.23 (-0.16%)
Close on Nov 12, 2026Market cap $362.55BP/E 151.5Yield 2.23%
Merck enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Merck's enterprise value was $414.20B on Nov 10, 2026, against $287.22B a year earlier. Over the last 5 years it ranged from $211.09B to $417.85B, with a median of $291.80B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $414.20B | +43.7% |
| 2025 | Dec 31, 2025 | $288.30B | +4.3% |
| 2024 | Dec 31, 2024 | $276.43B | -9.0% |
| 2023 | Dec 29, 2023 | $303.64B | +1.0% |
| 2022 | Dec 30, 2022 | $300.75B | +42.5% |
| 2021 | Dec 31, 2021 | $211.09B | -8.1% |
| 2020 | Dec 31, 2020 | $229.61B | -9.8% |
| 2019 | Dec 31, 2019 | $254.56B | +15.6% |
| 2018 | Dec 31, 2018 | $220.11B | +28.7% |
| 2017 | Dec 29, 2017 | $171.07B | -3.3% |
| 2016 | Dec 30, 2016 | $176.89B | +6.8% |
| 2015 | Dec 31, 2015 | $165.70B | -9.8% |
| 2014 | Dec 31, 2014 | $183.77B | +12.6% |
| 2013 | Dec 31, 2013 | $163.27B | +25.8% |
| 2012 | Dec 31, 2012 | $129.79B | +17.4% |
| 2011 | Jan 31, 2011 | $110.55B | -7.3% |
| 2010 | Dec 31, 2010 | $119.25B | – |
See a number that looks wrong?